Development of carbohydrate-based drug delivery systems

点击翻译按钮获取中文摘要

Chronic skin disorders affect 5% of the population. Treatment is challenging and long term because these disorders are chronic and unpredictable. Currently the most potent therapies for psoriasis are administered systemically. Long term usage of these therapies causes side effects such as kidney or liver damage. This proposal describes a new approach to the topical treatment of psoriasis where potent drugs are linked to a hyaluronan scaffold molecule and are directly applied to the diseased tissue. Advantages of this approach include targeted drug delivery mediated by hyaluronan receptor processes and potential amelioration of the observed drug toxicities.